Health TrialsbyHealthPanel

Substance Use in Assault-Injured Young Adults

ConditionsAlcohol MisuseCannabis Misuse
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorYale University

About this trial

This study aims to improve a short motivational conversation to better help young adults who were injured in assaults and also use alcohol or cannabis. Researchers will gather both interview and survey data from young adults who came to the emergency department after an assault and currently use alcohol or cannabis. Guided by a theory about risky behaviors, the study will focus on how confident young people feel about making changes to their alcohol and cannabis use, and how their friends and family influence their alcohol and cannabis use and involvement in injuries from assault. The team will follow a step-by-step process used by the NIH to adapt and test the improved motivational conversation in the emergency department.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Be clients of the Yale Hospital Violence Intervention Program (YHVIP)

Be between the ages of 18-25 y/o upon study enrollment

Have sustained an intentional injury inflicted by another person not considered to be a boy/girlfriend, fiancée, or spouse in the past year

Report current alcohol and/or cannabis misuse

Disqualifiers

Be actively suicidal or severely cognitively impaired precluding informed consent

Sustain an intentional injury from a boy/girlfriend, fiancée, or spouse or sexual assault

Be incarcerated or in police custody

Currently engaged in addiction treatment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Brief Negotiation Interview intervention (BNI) (adapted)

    Behavioral

    A brief motivational interview designed to increase motivation to reduce alcohol and/or cannabis use and engagement in treatment referral.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Brief Negotiation Interview intervention (BNI) (adapted)Experimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Feasibility assessed by recruitment

Recruitment measured as the percentage of those invited/those who enrolled

Time frame
Day 0 and 30
2

Feasibility assessed by randomization

Recruitment measured as the percentage of screened eligible participants who enroll/those who receive either intervention or control arm

Time frame
Day 0 and 30
3

Feasibility assessed by retention

Recruitment measured as the percentage of those enrolled who have received either intervention or control arm/ participants who have completed all 30-day follow up assessments

Time frame
Day 0 and 30
4

Acceptability assessed by Acceptability of Intervention Measure (AIM)

Acceptability of the intervention will be assessed using the Acceptability of Intervention Measure (AIM). It has 4-items scored on a 5-point Likert scale summed to achieve a total score. Total score range of 0-20. Higher scores indicate more acceptability.

Time frame
Day 0

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yale University

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: